Vincerx Pharma, Inc. Warrant

$3.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.81%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can watch VINCW and buy or sell other stocks, options, and ETFs commission-free!

About VINCW

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The firm pipeline is derived from a license agreement with Bayer and includes: a clinical-stage and follow-on small molecule drug program and preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company was founded by Ahmed Hamdy, Raquel Izumi, Tom Thomas, Stuart Hwang, and John Byrd is headquartered in Palo Alto, CA. The listed name for VINCW is Vincerx Pharma, Inc. Warrant.

CEO
Ahmed Hamdy, MD
Employees
—
Headquarters
Palo Alto, California
Founded
—
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
26.19K
High Today
$3.50
Low Today
$3.20
Open Price
$3.48
Volume
9.87K
52 Week High
$5.50
52 Week Low
$2.58

You May Also Like

SUSC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure